ELV · NYSE
Elevance Health Inc.
$439.95 -6.30 (-1.41%)
Company overview
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting them to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Exchange
- NYSE
- Market cap
- $95.4B
- Employees
- 104,200
- Headquarters
- Indianapolis, IN
- Website
- elevancehealth.com
- CEO
- Gail Koziara Boudreaux
- Listed
- October 30, 2001
- P/E
- 18.71
- Dividend yield
- 1.65%
Company financials
- Revenue
- $200B
- Gross profit
- $46.4B
- Operating income
- $7.6B
- EBITDA
- $8.9B
- Net income
- $5.2B
- EPS
- $23.51
- Total assets
- $126B
- Total debt
- $31.8B
- Gross margin
- 23.16%
- Net margin
- 2.62%
- Earnings yield
- 5.34%
No geographic segmentation.
Showing FY 2025
ELV
1D
NYSE
O432.56H449.95L431.20C445.28+11.15 (+2.57%)Vol1.43M